|Podcasts|September 17, 2020

Episode 65: Creating a Path for Innovation

George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.

You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010

ByNicholas Jacobus

June 19th 2026

Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive

ByNicholas Jacobus

June 18th 2026

Episode 65: Creating a Path for Innovation

Related Content

Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion

Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010

Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive

Trending on PharmExec

The Economics of the 340B Drug Pricing Program: Strategic Imperatives for the Life Sciences Industry in 2026

Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts

How 3D Printing Speeds Up Drug Production

FDA Pilot Targets Faster Early-Stage Drug Trial Starts

The Next Evolution of Class of Trade: Why Customer Identity Is Becoming Market Access’s Hardest Problem